5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 53.73▲ | 53.75▲ | 53.75▲ | 54.91▲ | 54.67▲ |
MA10 | 53.02▲ | 51.86▲ | 51.86▲ | 54.73▲ | 54.07▲ |
MA20 | 49.70▲ | 48.92▲ | 48.92▲ | 54.84▲ | 51.46▲ |
MA50 | N/A | N/A | N/A | 53.98▲ | 49.57▲ |
MA100 | N/A | N/A | N/A | 51.41▲ | N/A |
MA200 | N/A | N/A | N/A | 49.75▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.494▲ | 0.797▲ | 0.797▲ | -0.042▼ | 0.273▲ |
RSI | 66.494▲ | 66.187▲ | 66.187▲ | 58.889▲ | 65.369▲ |
STOCH | 89.809▲ | 96.434▲ | 96.434▲ | 56.769 | 84.119▲ |
WILL %R | -11.328▲ | -9.274▲ | -9.274▲ | -27.090 | -8.436▲ |
CCI | 73.649 | 72.704 | 72.704 | 70.488 | 90.744 |
Wednesday, July 30, 2025 04:28 AM
Key Insights Given the large stake in the stock by institutions, Jade Biosciences' stock price might be vulnerable ...
|
Tuesday, July 15, 2025 05:00 PM
Jade Biosciences has a 52-week low of $6.57 and a 52-week high of $105.00. The firm has a market capitalization of $7.21 million, a P/E ratio of -0.14 and a beta of 1.06.
|
Tuesday, July 08, 2025 04:14 AM
Jade’s Chief Executive Officer, Tom Frohlich, and Chief Scientific Officer and Head of R&D, Andrew King, BVMS, Ph.D., will participate in a fireside chat at the H.C. Wainwright 4th Annual Kidney ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
08/08/25 | 55.40 | 55.40 | 55.263 | 55.263 | 398 |
07/08/25 | 55.31 | 55.31 | 55.31 | 55.31 | 200 |
06/08/25 | 54.8666 | 54.8666 | 54.8666 | 54.8666 | 56 |
05/08/25 | 54.51 | 54.6663 | 54.51 | 54.6663 | 262 |
04/08/25 | 54.45 | 54.45 | 54.45 | 54.45 | 199 |
01/08/25 | 54.01 | 54.17 | 53.92 | 53.92 | 1,000 |
31/07/25 | 54.38 | 54.38 | 54.38 | 54.38 | 200 |
30/07/25 | 54.889 | 54.889 | 54.73 | 54.73 | 1,100 |
29/07/25 | 55.031 | 55.031 | 55.031 | 55.031 | 100 |
28/07/25 | 54.7212 | 54.7212 | 54.7212 | 54.7212 | 18 |
|
|
||||
|
|
||||
|
|